The Health Care M&A Monthly: Mylan Buys Matrix For $736 million: Buys Indian Firm To Enter Asian and European Markets
Email Editor Over the past year, we have covered deals in which Indian pharmaceutical companies stretched their wings and made acquisitions in Europe and the United States. With the dismantling of the “Permit Raj”—a hornet’s nest of bureaucracy and...The Health Care M&A Monthly: The Month in Deals –
July Sees 69 Deals Worth A Combined $35.5 Billion Email Editor The month of July saw a total of 69 mergers and acquisitions announced in 13 sectors of the health care industry, down 17% from the 81 deals announced in June. The nine sectors of the services segment...The Health Care M&A Monthly: One For the Record Book–
HCA Agrees To Be Taken Private For $33 Billion Email Editor For the second time in its history, hospital operator HCA, Inc. (NYSE: HCA) has agreed to be taken private. This time a group of private equity firms, along with HCA management and the founding Frist family,...The Health Care M&A Monthly: Bristol-Myers Squibb Builds a Bridge to New Revenues
After some weeks of speculation in the press, Bristol-Myers Squibb (NYSE: BMY) finally announced it would buy The DuPont Pharmaceutical Company, a subsidiary of E. I. Du Pont De Nemours (NYSE: DD), for $7.8 billion in cash. This deal advances both companies’ plans to...The Health Care M&A Monthly: The Second Quarter Health Care M&A Market
The health care industry saw a total of 263 mergers and acquisitions announced during the second quarter of 2006, up 11% from the 236 transactions announced in the prior quarter, Q1:06 and up 15% from the 228 deals announced in the year-ago quarter, Q2:05. The four...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
